Publications by authors named "Chengcheng Gong"

Claim this Profile
F
F-fluoroestradiol (F-FES) PET/CT for guiding first-line treatment in patients with HR + /HER2- metastatic breast cancer: impact on progression free survival.
Yizhao Xie, Yifan Chen, Cheng Liu, Yannan Zhao, Chengcheng Gong

Eur J Nucl Med Mol Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ARX788 for individuals with HER2-positive breast cancer and brain metastases (ACE-Breast-06): a single-arm, phase 2 trial in China.
Ting Li, Mingxi Lin, Biyun Wang, Mingchuan Zhao, Jun Cao, Chengcheng Gong

EClinicalMedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-specific ligase-dependent conjugation with ring-opening linker improves safety and stability of HER2-targeting ADCs.
Lei Huang, Gang Qin, Chengcheng Gong, Yajun Sun, Hui Yang

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision diagnosis and treatment of PI3K/AKT/PTEN signaling pathway in HR-positive advanced breast cancer: perspectives from Chinese experts.
Chengcheng Gong, Yue Hu, Yueping Liu, Shu Liu, Min Yan

Transl Breast Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of nomograms of outcomes for first-line platinum-based chemotherapy for metastatic triple-negative breast cancer: patient-level analysis of five prospective clinical trials in China.
Chengcheng Gong, Ting Li, Yifan Chen, Jian Zhang, Yannan Zhao

Ther Adv Med Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of utidelone in pretreated patients with metastatic breast cancer in China: a multicenter, real-world study.
Shihui Hu, Tengfei Chao, Ning Xie, Quchang Ouyang, Fei Xu, Chengcheng Gong

Ther Adv Med Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: DNA methylation-mediated expression of zinc finger protein 615 affects embryonic development in .
Guan-Feng Xu, Cheng-Cheng Gong, Yu-Lin Tian, Tong-Yu Fu, Yi-Guang Lin

Zool Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological characteristics, evolution, and treatment outcomes of hormone receptor-negative/HER2-low metastatic breast cancer: a pooled analysis of individual patient data from three prospective clinical trials.
Shihui Hu, Yannan Zhao, Yizhao Xie, Shuhui You, Xichun Hu, Chengcheng Gong

Front Endocrinol (Lausanne)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing predictions of remedial reagent transport via a vertical groundwater circulation well with high-resolution aquifer characterization.
Zaiyong Zhang, Jingbo Yang, Chengcheng Gong, Wenke Wang, Bin Ran

Sci Total Environ· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accessing 1,8-Naphthyridone-3-carboxylic Acid Derivatives and Application to the Synthesis of Amfonelic Acid.
Kaijuan Wang, Chengcheng Gong, Weiwei Xiao, Ablimit Abdukader, Dong Wang

J Org Chem· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ER status conversion and subsequent treatment: an assessment of negative ER expression detected by 18F-FES PET in metastatic breast cancer patients with ER-positive primary tumors.
Shuhui You, Yizhao Xie, Mengjing Ji, Cheng Liu, Yannan Zhao, Chengcheng Gong

Ther Adv Med Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological characteristics, evolution, treatment pattern and outcomes of hormone-receptor-positive/HER2-low metastatic breast cancer.
Shuhui You, Chengcheng Gong, Yi Li, Yizhao Xie, Yumeng Li

Front Endocrinol (Lausanne)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study.
Xin Liu, Chengcheng Gong, Jieyun Zhang, Wanjing Feng, Yanjing Guo

Cancer Res Treat· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score-matched analysis of real-world data.
Chengcheng Gong, Yizhao Xie, Yannan Zhao, Yi Li, Jian Zhang

Ther Adv Drug Saf· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diversity of the intestinal microbiota in patients with alcohol use disorder and its relationship to alcohol consumption and cognition.
Yishan Du, Lin Li, Chengcheng Gong, Ting Li, Yan Xia

Front Psychiatry· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer.
Chengcheng Gong, Cheng Liu, Zhonghua Tao, Jian Zhang, Leiping Wang

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation-mediated expression of zinc finger protein 615 affects embryonic development in .
Guan-Feng Xu, Cheng-Cheng Gong, Yu-Lin Tian, Tong-Yu Fu, Yi-Guang Lin

Zool Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy Shows a Better Efficacy Than Endocrine Therapy in Metastatic Breast Cancer Patients with a Heterogeneous Estrogen Receptor Expression Assessed by F-FES PET.
Yizhao Xie, Xinyue Du, Yannan Zhao, Chengcheng Gong, Shihui Hu

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity derived from F-FDG PET/CT predicts immunotherapy outcome for metastatic triple-negative breast cancer patients.
Yizhao Xie, Cheng Liu, Yannan Zhao, Chengcheng Gong, Yi Li

Cancer Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic transcriptome analysis of Bombyx mori embryonic development.
Guan-Feng Xu, Cheng-Cheng Gong, Hao Lyu, Hui-Min Deng, Si-Chun Zheng

Insect Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of chidamide in combination with cisplatin in patients with metastatic triple-negative breast cancer.
Yanchun Meng, Juan Jin, Chengcheng Gong, Haitao Miao, Zhonghua Tao

Ann Palliat Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases.
Yizhao Xie, Chengcheng Gong, Jian Zhang, Leiping Wang, Jun Cao

BMC Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An assessment of different methods to determine specific yield for estimating groundwater recharge using lysimeters.
Chengcheng Gong, Zaiyong Zhang, Wenke Wang, Lei Duan, Zhoufeng Wang

Sci Total Environ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: a multicenter retrospective study.
Yannan Zhao, Ning Xie, Wei Li, Wenyan Chen, Zheng Lv, Chengcheng Gong

Ther Adv Med Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter analysis of treatment patterns and clinical outcomes of subsequent therapies after progression on palbociclib in HR+/HER2- metastatic breast cancer.
Yi Li, Wei Li, Chengcheng Gong, Yabin Zheng, Quchang Ouyang

Ther Adv Med Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis